RocketTickers

Emergent BioSolutions Announces FDA Approval of NARCAN® (naloxon

Long
NYSE:EBS   Emergent Biosolutions, Inc.
EBS: Emergent BioSolutions
2020-08-17 06:30:10
Emergent BioSolutions Announces FDA Approval of NARCAN® (naloxone HCl) Nasal Spray Shelf Life Extension to 36 Months
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.